Headlines
•Tiger Global invests $180M in Intel — shares up 404% in one year, breaking through dot-com era highs
•Nebius CEO commits to $25B annual capex — spending plan doubles down from $20B target
•Maze Therapeutics stock still up 180% after March tumble — one fund discloses selling $3M in shares
•Obesity drug stock jumps 60% as Phase 3 plans advance — one fund sells $4.7M in shares
•Walmart stock hits double-top resistance ahead of earnings — valuation concerns emerge as shares test key level
•SA Asks: Which stocks are most exposed to a Chinese blockade of Taiwan? (TSM:NYSE)
•The AI Stock With a 10-Year Head Start That Wall Street Still Hasn't Fully Priced In